AI-assisted cardiac ultrasound guidance software receives De Novo clearance

AI-assisted cardiac ultrasound guidance software receives De Novo clearance

The first artificial intelligence-enabled cardiac ultrasound software has received De Novo marketing authorization, the FDA announced today. Developed by Caption Health, the Caption Guidance tool guides medical professionals through a heart disease diagnostic test that normally requires an ultrasound expert.

“Echocardiograms are one of the most widely-used diagnostic tools in the diagnosis and treatment of heart disease,” Robert Ochs, deputy director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health, said in a statement. “Today’s marketing authorization enables medical professionals who may not be experts in ultrasonography, such as a registered nurse in a family care clinic or others, to use this tool.”




Next Article

  • Rising Telehealth Adoption Among Trends Highlighted in AMA Survey

    Rising Telehealth Adoption Among Trends Highlighted in AMA Survey

    Physician adoption of telehealth and virtual visits doubled from 14 percent in 2016 to 28 percent in 2019, according to survey research from the American Medical Association. The growth in the use of …

    Posted Feb 11, 2020telehealth

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 28, 2024 at 3:00am